ClinConnect ClinConnect Logo
Search / Trial NCT05730582

Increasing Uptake of EHR-enabled Population Health Outreach Strategies to Improve Diabetes Screening

Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Feb 6, 2023

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Diagnostic Screening Program Health System Intervention

ClinConnect Summary

The research team will conduct a pragmatic, split cluster randomized controlled trial (clinic=cluster; patient randomization) in 12 community-based primary care clinics in an integrated safety net health system serving a high-risk, racially/ethnically diverse population.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient is alive at time of data extraction
  • Age \>= 18 at time of data extraction and \<76
  • Visit with PCP at Parkland clinic in the last 18 months (548 days), where Encounter type = Virtual Visit or Encounter type = Office Visit
  • Patient NOT included in Parkland Diabetes Registry
  • Preferred language is Spanish or English
  • Ethnicity is Hispanic or Non-Hispanic
  • Race is White or Black
  • Patient is not pregnant in last 12 months
  • Exclusion Criteria for Study Population 1: Prediabetes Glycemic Risk Group
  • Last A1C value \<5.7 (normal)
  • Last A1C value \>6.4 (diabetes)
  • Last A1C value = blank (unchecked)
  • Last A1C date occurred within last 12 months from date of export
  • Exclusion Criteria for Study Population 2: Score-Based Glycemic Risk Group
  • Risk score \<9
  • Last A1C date occurred in last 30 months from date of export
  • Last A1C value was \>5.7 (PDM/DM)

About University Of Texas Southwestern Medical Center

The University of Texas Southwestern Medical Center is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical excellence. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing novel therapies and improving patient outcomes across a wide range of diseases. Its multidisciplinary approach leverages a collaborative network of renowned faculty, state-of-the-art facilities, and a commitment to ethical research practices, positioning UT Southwestern at the forefront of medical discovery and patient care.

Locations

Dallas, Texas, United States

Patients applied

0 patients applied

Trial Officials

Michael Bowen, MD

Principal Investigator

University of Texas Southwestern Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials